EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Dynamic optimization of an integrated cultivation‐aggregation model for mAb production

Wil Jones, Dimitrios I Gerogiorgis

Biotechnology and Bioengineering · 2024

DOI: 10.1002/bit.28761 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2024. Written by Wil Jones and 1 co-authors. Institution: School of Engineering, Institute for Materials and Processes (IMP), University of Edinburgh, Edinburgh, Scotland, UK. Major MEDLINE topics: Cricetulus, Antibodies, Monoclonal, Bioreactors. Cited 1 times so far (Crossref); 46 references. The full text is freely available (open access, CC BY 4.0). Funded by: Royal Society, Engineering and Physical Sciences Research Council.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Due to their proteinaceous structure, monoclonal antibodies (mAbs) are susceptible to irreversible aggregation, with harmful consequences on drug efficacy and patient safety. To mitigate this risk in modern biopharmaceutical processes, it is critical to comply with current good manufacturing practices (cGMP) and pursue operating strategies minimizing irreversible aggregation whilst also maximizing mAb throughput. These conflicting objectives are targeted in this study by formulating and analyzing an integrated dynamic model accounting for both cultivation and aggregation of mAbs from a Chinese Hamster Ovary (CHO) cell line. Two manipulated dynamic variables are considered here in simulation studies: firstly temperature manipulation within a batch reactor, and secondly feed flow manipulation within a series of isothermal fed‐batch reactors. Following this, dynamic optimization investigations have been conducted, firstly with the single objective of maximizing mAb throughput and secondly with multiple (two) objectives of maximizing mAb throughput while also minimizing irreversible aggregate content, simultaneously. The study provides key insight into tradeoffs of how simultaneous temperature and feed flowrate manipulation affects mAb throughput and aggregation inside bioreactors.

Subjects

MeSH terms (MEDLINE)

CricetulusAntibodies, MonoclonalBioreactorsCHO CellsAnimalsProtein AggregatesCricetinaeTemperatureCell Culture TechniquesBatch Cell Culture TechniquesModels, Biological

Author keywords

dynamic optimizationdynamic simulationmonoclonal antibodies (mAb)protein aggregation

Substances

Antibodies, MonoclonalProtein Aggregates

Authors and institutions

  • School of Engineering, Institute for Materials and Processes (IMP), University of Edinburgh, Edinburgh, Scotland, UK.

Funding

  • Royal Society
  • Engineering and Physical Sciences Research Council

Cite

APA

Jones, W., & Gerogiorgis, D. I. (2024). Dynamic optimization of an integrated cultivation‐aggregation model for mAb production. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.28761

Vancouver

Jones W, Gerogiorgis DI. Dynamic optimization of an integrated cultivation‐aggregation model for mAb production. Biotechnology and Bioengineering. 2024. doi:10.1002/bit.28761

BibTeX
@article{Jones2024,
  author = {Jones, Wil and Gerogiorgis, Dimitrios I},
  title = {Dynamic optimization of an integrated cultivation‐aggregation model for mAb production},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  doi = {10.1002/bit.28761}
}
Start for free →